Skip to main content

Abstract

As full implementation of the Affordable Care Act approaches, researchers are analyzing available data to reduce uncertainty about the future and help measure the effects of anticipated changes. This analysis of 1985–2005 data provides a baseline for understanding how the ACA and national parity will shift funding for specialty mental health and substance abuse treatment. The researchers documented substantial changes for hospital-based care, office-based providers, and specialty centers. They note that future spending increases are likely under both private insurance and Medicaid and that parity in private plans will shift payment sources for office-based professionals.

Abstract

Objectives

Goals were to describe funding for specialty behavioral health providers in 1986 and 2005 and examine how the recession, parity law, and Affordable Care Act (ACA) may affect future funding.

Methods

Numerous public data sets and actuarial methods were used to estimate spending for services from specialty behavioral health providers (general hospital specialty units; specialty hospitals; psychiatrists; other behavioral health professionals; and specialty mental health and substance abuse treatment centers).

Results

Between 1986 and 2005, hospitals—which had received the largest share of behavioral health spending—declined in importance, and spending shares trended away from specialty hospitals that were largely funded by state and local governments. Hospitals’ share of funding from private insurance decreased from 25% in 1986 to 12% in 2005, and the Medicaid share increased from 11% to 23%. Office-based specialty providers continued to be largely dependent on private insurance and out-of-pocket payments, with psychiatrists receiving increased Medicaid funding. Specialty centers received increased funding shares from Medicaid (from 11% to 29%), and shares from other state and local government sources fell (from 64% to 46%).

Conclusions

With ACA’s full implementation, spending on behavioral health will likely increase under private insurance and Medicaid. Parity in private plans will also push a larger share of payments for office-based professionals from out-of-pocket payments to private insurance. As ACA provides insurance for formerly uninsured individuals, funding by state behavioral health authorities of center-based treatment will likely refocus on recovery and support services. Federal Medicaid rules will increase in importance as more people needing behavioral health treatment become covered.
Of the $135 billion spent on treatment of behavioral health disorders in 2005, 22% went for the purchase of prescription drugs and 7% for the administrative costs of public and private insurers. The remaining 70% ($95 billion) was paid to specific providers, with three-quarters ($74.3 billion) going to specialty behavioral health providers (1). Specialty providers include general hospitals with specialty behavioral health units; specialty psychiatric and chemical dependency hospitals; psychiatrists; other behavioral health professionals, including psychologists and clinical social workers; and specialty mental health and specialty substance abuse treatment centers. The training and experience of professionals delivering specialty behavioral health services equip them to effectively diagnose and treat behavioral health disorders, particularly among persons with serious and persistent illnesses (2,3). These professionals are also more likely to provide guideline-concordant behavioral therapies in addition to pharmacotherapy, which often improves outcomes (46).
Specialty providers differ from other providers in the funding sources used to pay for their services. Compared with funding sources for health spending in general, sources for specialty behavioral health care spending are more likely to be public insurance programs and grants (7). With the approach of the full implementation of the Affordable Care Act (ACA), specialty behavioral health providers will face funding changes. It is important to understand how services delivered by these specialty providers were financed in the past and the likely impacts that providers will face as a result of changes in funding. In this study, we identified historical trends in financing of services of specialty behavioral health providers. These trends can provide a baseline for studying future policy impacts. We speculate about how the recession and recent legislation will change these financing sources over the next few years.

Methods

This analysis is an outgrowth of a larger study conducted for the Substance Abuse and Mental Health Services Administration (SAMHSA) that estimated national spending on mental health and substance abuse treatment by payer and provider type (1,8). The study presented here is the first examination of detailed sources of reimbursement at the provider level by using these estimates. This study focused on funding for specialty provider services; it excluded spending for nonspecialty providers, such as nonspecialty units in general hospitals, nonpsychiatric physicians, nursing homes, and home health agencies, as well as spending for prescription drugs and the administrative costs of private and public insurance. [A list of specialty providers included in this study, along with the typical services that they provide and the populations that they serve, is presented in an online supplement to this article.] The estimates are based on information from a number of surveys and administrative data sets, including SAMHSA’s Survey of Mental Health Organizations and National Survey of Substance Abuse Treatment Services, as well as the Economic Census for the health care and social assistance sector, Census Services Annual Survey, and Medicare Hospital Cost Reports. The methods used to produce these estimates are described in detail elsewhere (1).
Two approaches were used to estimate behavioral health treatment expenditures. The first method measured spending for psychiatric hospitals, psychiatric units in community hospitals, and specialty behavioral health centers by using SAMHSA’s two national surveys of specialty organizations, the Survey of Mental Health Organizations and the National Survey of Substance Abuse Treatment Services, augmented with data from the National Hospital Ambulatory Medical Care Survey, the National Ambulatory Medical Care Survey, the Healthcare Cost and Utilization Project, and Medicare Hospital Cost Reports. In the second approach, spending was estimated by payer for psychiatrists and other professionals by using the proportion of all-health spending from the National Health Expenditure Accounts (7) attributable to behavioral health conditions. The proportions were developed by using patient encounter data from surveys such as the National Ambulatory Medical Care Survey and the Medical Expenditure Panel Survey, adjusted for cost differences for visits and stays for all health compared with behavioral health. Data from the Economic Census were also used.
To define behavioral health disorders, only principal diagnoses identified by the International Classification of Diseases, Ninth Revision, Clinical Modification were used: codes in sections 290 through 319 (mental disorders) as well as 648.3 and 648.4 (pregnancy complications related to mental illness or substance use disorders). Excluded were codes for organic brain disease, cerebral degenerations, developmental delays, intellectual disabilities, and tobacco addiction.

Results

Specialty providers and their funding, 1986 and 2005

Tables 1 and 2 present estimates and percentage distributions of behavioral health spending by payer for 1986 and 2005 grouped by general treatment sites (hospitals, offices, and specialty behavioral treatment centers) and by specific type of provider. Of the $74.3 billion in specialty behavioral health treatment spending in 2005, 39% went for hospital-based care, 26% for office-based treatment, and 35% for center-based care. In 1986, a total of $26.4 billion was spent on specialty behavioral health treatment. Between 1986 and 2005, the share of spending on specialty hospital services fell from 58% to 39%. The share for office-based treatment rose from 20% to 26%, and the share for center-based care rose from 23% to 35%.
Table 1 Expenditures (in millions of dollars) for mental health and substance abuse treatment, by specialty provider and payer, 1986 and 2005a
Provider type and payer categoryTotal    
198620051986200519862005
Hospital-based specialty providers General hospital specialty unitsSpecialty hospitals
 Total spending15,19229,0125,53114,3829,66014,630
 Private total4,9365,1492,0972,8272,8392,322
  Out of pocket705794433470272324
  Private insurance3,8033,5851,5231,9432,2801,642
  Other private428770141414287356
 Public total10,25623,8633,43411,5556,82112,308
  Medicare1,1953,6475512,2706441,377
  Medicaid1,6206,6786223,4049983,273
  Other federalb1,5483,4381,4583,32590113
  Other state and local5,89210,1018022,5565,0907,545
  All federalc3,63710,9512,3537,5661,2843,385
  All stated6,61912,9121,0813,9895,5378,923
Office-based specialty providers PsychiatristsOther professionals
 Total spending5,16219,4572,99311,8852,1697,572
 Private total3,73513,1272,2998,0551,4365,071
  Out of pocket1,6525,7111,0823,6315702,080
  Private insurance1,6996,2871,0053,7316942,556
  Other private3841,129212693172435
 Public total1,4276,3316933,8307332,501
  Medicare2641,6931601,084104609
  Medicaid5182,6081441,4133741,196
  Other federalb25263339248213385
  Other state and local3931,3973511,08641311
  All federalc8033,8442812,1625231,682
  All stated6242,4874131,667211819
Center-based providers Specialty mental health centersSpecialty substance abuse treatment centers
 Total spending6,02925,8314,24116,2111,7889,621
 Private total7722,4705421,1812301,288
  Out of pocket16883062280106550
  Private insurance4121,01232638086632
  Other private19262715452138106
 Public total5,25723,3623,69915,0301,5588,332
  Medicare124682996142468
  Medicaid6547,3864446,0122091,374
  Other federalb6483,4594411,1092072,350
  Other state and local3,83211,8342,7147,2951,1174,539
  All federalc1,1418,3127925,1173493,195
  All stated4,11615,0502,9089,9121,2085,138
a
Source: Substance Abuse and Mental Health Services Administration, National Expenditures for Mental Health Services and Substance Abuse Treatment, 1986–2005 (1)
b
Includes federal block grants to state and local governments
c
Includes Medicare, the federal portion of Medicaid, and other federal sources
d
Includes the state and local portion of Medicaid and other state and local sources
Table 2 Percentage distribution of expenditures for mental health and substance abuse treatment, by specialty provider and payer, 1986 and 2005a
 Total    
Payer category198620051986200519862005
Hospital-based specialty providers General hospital specialty unitsSpecialty hospitals
 Total spending (in millions)$15,192$29,012$5,531$14,382$9,660$14,630
 Total spending (%)      
  Private total321838202916
   Out of pocket538332
   Private insurance251228142411
   Other private333332
  Public total688262807184
   Medicare813101679
   Medicaid112311241022
   Other federalb1012262311
   Other state and local393515185352
   All federalc243843531323
   All stated444520285761
Office-based specialty providers PsychiatristsOther professionals
 Total spending (in millions)$5,162$19,457$2,993$11,885$2,169$7,572
 Total spending (%)      
  Private total726777686667
   Out of pocket322936312627
   Private insurance333234313234
   Other private767686
  Public total283323323433
   Medicare595958
   Medicaid10135121716
   Other federalb5312105
   Other state and local8712924
   All federalc16209182422
   All stated121314141011
Center-based providers Specialty mental health centersSpecialty substance abuse treatment centers
 Total spending (in millions)$6,029$25,831$4,241$16,211$1,788$9,621
 Total spending (%)      
  Private total13101371313
   Out of pocket331266
   Private insurance748257
   Other private324321
  Public total879087938787
   Medicare232411
   Medicaid112910371214
   Other federalb11131071224
   Other state and local644664456247
   All federalc193219322033
   All stated685869616853
a
Source: Substance Abuse and Mental Health Services Administration, National Expenditures for Mental Health Services and Substance Abuse Treatment, 1986–2005 (1)
b
Includes federal block grants to state and local governments
c
Includes Medicare, the federal portion of Medicaid, and other federal sources
d
Includes the state and local portion of Medicaid and other state and local sources

Hospital-based providers

In 2005 the $29.0 billion spent for hospital-based specialty behavioral health treatment was evenly distributed between general hospital specialty units ($14.4 billion) and specialty hospitals ($14.6 billion).
In 2005, Medicaid and “other federal” sources each accounted for about one-quarter of spending for care in specialty units of general hospitals. “Other federal” sources include spending by the U.S. Department of Veterans Affairs (VA) in specialty units of VA hospitals. In specialty hospitals, “other state and local” government sources accounted for more than half of expenditures in 2005, reflecting states’ responsibility for state psychiatric hospital treatment of forensic and other patients committed to inpatient psychiatric care.
In 2005, private sources paid for 20% or less of treatment in both hospital settings. Private insurance payments alone amounted to 14% of all spending in specialty units of general hospitals and 11% of all spending in specialty hospitals. In comparison, private insurance payments in 2005 accounted for 37% of hospital treatment for all health conditions (7).
For specialty units of general hospitals, the share of spending accounted for by private insurance fell from 28% in 1986 to 14% in 2005; this decrease was accompanied by an almost equal increase in Medicaid spending—from 11% in 1986 to 24% in 2005. For specialty hospitals, similar trends were noted: an increased share of Medicaid (from 10% to 22%) and a reduction in the share paid by private insurance (from 24% to 11%). In specialty hospitals, the single largest payer for behavioral health treatment (“other state and local” government sources) continued to fund more than half of all spending in specialty hospitals—53% in 1986 and 52% in 2005.

Office-based providers

Of the $19.5 billion spent for office-based specialty behavioral health treatment in 2005, 61% was for treatment by psychiatrists and 39% was for treatment by other licensed behavioral health professionals.
In 2005, private financing accounted for a majority of spending on services of office-based specialty behavioral health provider—67%. For both psychiatrists and other professionals, private insurance—the single largest payer—funded approximately one-third of all spending. Out-of-pocket payments accounted for significant shares of office-based spending: 31% for psychiatrists and 27% for other professionals. Only about one-third of all spending for office-based specialty behavioral health treatment came from public payers. Medicaid accounted for 12% of spending for treatment by psychiatrists and 16% of spending for treatment by other professionals.
Between 1986 and 2005, the shift in funding sources for office-based professionals was more modest than for hospitals. The shares accounted for by private insurance payments and out-of-pocket spending dropped slightly for psychiatrists and remained mostly unchanged for other professionals. The share paid by public funding sources increased from 23% in 1986 to 32% in 2005 for psychiatrists but remained fairly stable for other professionals (34% in 1986 and 33% in 2005).

Center-based providers

In 2005, a total of $25.8 billion was spent for center-based behavioral health specialty treatment. Specialty mental health centers accounted for 63%, and specialty substance abuse treatment centers accounted for 37%. Center-based providers depended heavily on public-sector financing of treatment. Public sources accounted for 93% of spending for specialty mental health centers and 87% of spending for specialty substance abuse treatment centers.
In 2005 “other state and local” sources (that is, sources other than Medicaid) accounted for the single largest share of treatment financing for center-based providers—45% of spending in specialty mental health centers and 47% in specialty substance abuse treatment centers. For mental health centers, another 37% of funding came from Medicaid. For substance abuse treatment centers, “other federal” payers, which included SAMHSA substance abuse treatment block grants, accounted for 24% of spending; Medicaid (14% of spending) was also important. In 2005, the share paid by private funding sources was the smallest for any specialty behavioral health provider—only 7% of specialty mental health center spending and 13% of specialty substance abuse treatment center spending.
For specialty mental health and substance abuse treatment centers, the share of funding from “other state and local” sources fell between 1986 and 2005. For specialty substance abuse treatment centers, this reduction was offset by an increase in the share of spending by “other federal” sources. It was also offset, but to a much smaller extent than was seen in specialty mental health centers, by an increase in the Medicaid spending share. The proportion of “other federal” spending in specialty substance abuse treatment centers doubled over this time period.

Discussion

The shift in funding sources for specialty behavioral health providers has been more prominent for hospital- and center-based providers than for office-based providers. The historical changes in funding sources are a prelude to potentially larger shifts in funding resulting from new legislation and economic events since 2005.

Historical financing

Among payers for hospital-based treatment, Medicaid funding accounted for the largest share increase from 1986 to 2005. Because Medicaid is an entitlement program, eligibility and costs are more difficult to control than are direct subsidies by state agencies (9). Despite the general prohibition against Medicaid payments for inpatient treatment of persons aged 22–64 in institutions for mental disease (IMDs) with more than 16 beds, Medicaid’s share of funding for specialty hospitals has been increasing. States employ managed care waivers that have allowed IMDs to receive Medicaid payments for those otherwise excluded from IMDs. States have also increased inpatient treatment of children and adolescents, who are exempt from the IMD restrictions, for diagnostic and medical evaluations and for medication stabilization and adjustments (10). Medicaid disproportionate share hospital (DSH) payments provide additional funding to hospitals serving a disproportionate share of people with low income. DSH payments to state-owned specialty hospitals, which increased rapidly in 1991–1992 before limits were enacted, may have also contributed to the increase (11).
In 2005, office-based behavioral health providers depended more than any other group of specialty providers on private payments from insurance and out-of-pocket sources. Historically, private insurance has often imposed limits on the number of behavioral health visits and has also imposed higher cost-sharing requirements not found for other outpatient services (12). These restrictions resulted in privately insured patients directly paying large shares of treatment costs. Because of shortages of providers in some geographic areas, office-based specialty providers have been able to limit the number of patients from Medicaid and other public payers, which typically reimburse at lower rates (11,13), resulting in only a small share of payments from public sources.
Patients seen by center-based providers are often uninsured or covered by Medicaid. In 2005, more than 90% of funding for center-based providers came from public sources. Between 1986 and 2005, a shift in public funding sources for these providers included a decrease in the share paid by other state and local sources (non-Medicaid) and an increase in spending share by Medicaid, especially for specialty mental health treatment centers. The larger Medicaid share in center-based providers resulted from the shift in treatment sites from hospital and other institutional settings, where Medicaid funding was restricted, to outpatient settings, where treatments for Medicaid enrollees were more likely to be paid by Medicaid (14). Specialty substance abuse treatment providers experienced increases in other federal funding from SAMHSA block grants, the VA, and the Department of Defense (DoD)—agencies that are increasingly focused on mental health and substance abuse treatment within their constituent populations.
Specialty substance abuse centers receive a low share of Medicaid spending and a high share of spending from other state and local sources. In part, this stems from substantial differences among states in Medicaid coverage for substance abuse treatment in residential settings and the large criminal justice population that states serve (15). Credentialing requirements for substance abuse treatment professionals and facilities are less medically oriented than those demanded by Medicaid, which means that many substance abuse treatment facilities do not participate in Medicaid (16). In addition, specialty substance abuse centers operate on capacity grants and contracts from state mental health and substance abuse treatment authorities, thus avoiding the added overhead expense of third-party billing and documentation required to submit insurance claims. This practice has raised concern that many specialty substance abuse treatment centers will need to add a business infrastructure to handle the documentation and billing responsibilities under the Medicaid expansion and state health insurance exchanges, which will extend coverage to many who are currently uninsured.

Recent financing, 2006–2013

New legislation, interacting with the effects of the recession and the increased focus on the behavioral health treatment needs of veterans and the military, is expected to further change the distribution of financing of behavioral health treatment by specialty providers from 2006 to 2013.
The Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) expanded coverage for behavioral health treatment within employer insurance plans to be on par with that for medical-surgical care in regard to limits on visits and inpatient stays and cost-sharing requirements (17). The MHPAEA likely resulted in a small shift of out-of-pocket spending to private insurance in 2010–2011 as the parity requirements were implemented. MHPAEA is expected to raise private health insurance premiums—but by less than 1% (18). The premium increase will be small because even a substantial upturn in spending on behavioral health treatment will amount to only a small portion of all private insurance payments for all conditions.
The ACA includes some provisions with an impact on behavioral health treatment spending before the full implementation in 2014. These provisions include expansion of coverage through age 26 for adult dependent children, the establishment of insurance coverage for persons with preexisting conditions, and the prohibition of lifetime dollar limits on coverage by private insurance plans (19). The increase in enrollment- and benefits-related costs for private insurance plans is expected to be tempered by the loss of employment-related health insurance among an estimated 9.7 million workers and their families from 2007 to 2010 (20).
Some of these unemployed persons and their families were among the 7.6 million added to the Medicaid rolls from 2007 to 2010 (20). In addition, ACA gave states the option to provide coverage under Medicaid to childless adults up to 133% of the federal poverty level (FPL) before 2014, increasing enrollment even further in some states. To ease the Medicaid financial burden on states that accompanied higher enrollment, Congress passed legislation to enhance the federal Medicaid match beginning in federal fiscal year 2009 for up to 11 quarters (21). Although the enhanced match did not change the Medicaid share of specialty provider funding, it reduced states’ responsibility in matching federal Medicaid spending. In 2011, the expiration of the enhanced Medicaid match rate may have led to cuts in eligibility, benefit coverage, or provider reimbursement as states tried to balance their budgets (21,22). State behavioral health agencies’ inability to maintain funding for specialty hospital- and center-based providers resulted in further closures of state psychiatric hospitals and other center-based behavioral health providers (2325). For the federal government, the increased recognition of behavioral health needs of military personnel and veterans should result in an increase in federal funding through the VA and the DoD during a period when federal spending through SAMHSA mental health and substance abuse block grants remained flat (26).

Future financing, 2014 and beyond

Behavioral health patients are expected to be positively affected by the ACA when it becomes fully implemented in 2014 because people with behavioral health conditions are disproportionately poor and uninsured.
In 2014, ACA will expand Medicaid coverage to people up to 65 years of age who are uninsured and have incomes up to 133% of the FPL. The 2012 Supreme Court decision will allow states to opt out of the Medicaid expansion without penalty and may alter expected enrollment levels, leaving some people with low income, who were expected to be covered, without insurance (27). For those between 133% and 400% of the FPL, including persons formerly covered by Medicaid, health insurance will be subsidized on a sliding scale through health insurance exchanges; all legal residents—including young adults, who are often uninsured—must enroll in health insurance or pay a penalty. In addition, small-group employers with fewer than 100 workers will be able to select insurance for their workers in the “marketplace” from affordable, qualified health plans that provide behavioral health benefits. For specialty providers, these changes are expected to boost the share of financing from private insurance and Medicaid (28).
Hospital- and center-based providers should see a continuing shift in behavioral health treatment financing from other state and local sources to Medicaid as enrollment in Medicaid increases and the Medicaid program covers care for formerly uninsured persons. However, because of the expected reduction in the number of uninsured persons, the ACA mandates cuts in Medicare and Medicaid DSH payments to hospitals—payments that were originally designed to offset costs incurred in serving a disproportionate share of uninsured patients. Specialty centers, which receive the bulk of SAMHSA mental health and substance abuse block grants, may see a repurposing of these funds for nonmedical, community-based recovery supports and rehabilitative services, which may not be well covered by Medicaid or private insurance. Specialty centers may also find new funding opportunities by partnering with or integrating behavioral health services with primary care provided by Federally Qualified Health Centers—organizations that will receive additional funding under the ACA (29).

Conclusions

Historical sources of financing of treatment have changed substantially for many specialty behavioral health providers. Over the next few years, major transformations in the financing of behavioral health treatment supplied by specialty providers will take place as the ACA is implemented. First, spending for specialty providers has been trending away from services in specialty behavioral health hospitals. For public facilities, the shortfalls in state revenue may force further closures of hospital beds operated by state governments. Such closures place increased demand on general hospitals to treat patients in need of acute behavioral health care. However, general hospitals already face pressures. Some psychiatric units have been closed, and many general hospital emergency departments are overcrowded because hospitals lack psychiatric beds in which to place patients.
Second, treatment by office-based professionals has historically been financed by private payers. Parity will push more behavioral health payments from out-of-pocket to private insurance as visit limits and copayments are brought in line with those for medical-surgical care. Because of the increase in the number of people with private insurance as a result of the ACA, there will be increased demand for the services of a limited number of office-based professionals, which could drive up the price for these scarce services.
Third, with the decline in the number of uninsured individuals under the ACA, we expect a continuing drop in the share of financing of specialty center–based provider services through grants and contracts from state behavioral health authorities. Although the role of other state financing (non-Medicaid) will likely remain important for those who remain uninsured and for services not covered by public and private insurers, the relative importance of state and local funding will probably diminish as private insurance and Medicaid become insurers for many formerly uninsured people.
Fourth, the importance of funding under federal rules governing Medicaid will accelerate. Medicaid programs are increasingly paying attention to the behavioral health population that is expected to grow disproportionately under the ACA. This is an opportunity for state behavioral health authorities to coordinate with state Medicaid agencies to more closely integrate funding streams and continuity of care for persons with behavioral health problems.
Last, spending by both public and private insurance is likely to increase for behavioral health conditions. The parity law may increase private insurance spending to the extent that demand for services was curtailed by limits on visits and stays and by higher cost-sharing requirements under private insurance plans. The largest effects, however, will come through Medicaid expansion and the insurance exchanges. Although the increase in private insurance enrollees through the exchanges (20 million persons) is expected to outweigh the Medicaid enrollee increase (17 million), the incidence of significant mental and substance use conditions is disproportionately high in the Medicaid expansion population (30), increasing the likelihood of similar growth in behavioral health spending for both populations.
These predictions are based on historical trends estimated as part of the SAMHSA spending estimates (1), from a critical review of changing legal requirements on the health care industry, and from an assessment of various studies on behavioral health care. Through its spending estimates and other resources, SAMHSA will continue to monitor the trends and financing shifts in behavioral health care and compare them with trends and shifts in overall health care. SAMHSA will also offer support to providers as they adjust to the substantial changes that lie ahead.

Acknowledgments and disclosures

This work was funded by SAMHSA under contract HHS-S-270-2006-00023C. This article does not necessarily reflect the views or policies of SAMHSA or the Department of Health and Human Services, and the authors are solely responsible for its content.
The authors report no competing interests.

Supplementary Material

Supplemental Material (512_ds001.pdf)

References

1.
National Expenditures for Mental Health Services and Substance Abuse Treatment, 1986–2005. DHHS pub no (SMA) 10-4612. Rockville, Md, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services and Center for Substance Abuse Treatment, 2010
2.
Coyle JT, Pine DS, Charney DS, et al.: Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 42:1494–1503, 2003
3.
Lieberman J: The use of antipsychotics in primary care. Primary Care Companion to the Journal of Clinical Psychiatry 5(supp 3):3–8, 2003
4.
Pampallona S, Bollini P, Tibaldi G, et al.: Combined pharmacotherapy and psychological treatment for depression: a systematic review. Archives of General Psychiatry 61:714–719, 2004
5.
Meyer JM: Treating the mind and body in schizophrenia: risks and prevention. CNS Spectrums 9(suppl 11):25–33, 2004
6.
Chen SY, Hansen RA, Farley JF, et al.: Follow-up visits by provider specialty for patients with major depressive disorder initiating antidepressant treatment. Psychiatric Services 61:81–85, 2010
7.
Catlin A, Cowan C, Heffler S, et al.: National health spending in 2005: the slowdown continues. Health Affairs 26:142–153, 2007
8.
Mark TL, Levit KR, Vandivort-Warren R, et al.: Changes in US spending on mental health and substance abuse treatment, 1986–2005, and implications for policy. Health Affairs 30:284–292, 2011
9.
Buck JA: Medicaid, health care financing trends, and the future of state-based public mental health services. Psychiatric Services 54:969–975, 2003
10.
Rosenbaum S, Teitelbaum J, Maury DJ: An Analysis of the Medicaid IMD Exclusion, 2002. Available at www.gwumc.edu/sphhs/departments/healthpolicy/CHPR/downloads/behavioral_health/reports/IMD%20Report%201202.pdf
11.
Frank RG, Goldman HH, Hogan M: Medicaid and mental health: be careful what you ask for. Health Affairs 22:101–113, 2003
12.
National Compensation Survey: Employee Benefits in Private Industry in the United States, 2005. Washington, DC, US Department of Labor, Bureau of Labor Statistics, 2007. Available at www.bls.gov/ncs/ebs/sp/ebbl0022.pdf
13.
Cunningham P, McKenzie K, Taylor EF: The struggle to provide community-based care to low-income people with serious mental illnesses. Health Affairs 25:694–705, 2006
14.
Verdier J, Barrett A, Davis S: Administration of Mental Health Services by Medicaid Agencies. DHHS pub no (SMA) 07-4301. Rockville, Md, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services and Center for Substance Abuse Treatment, 2007. Available at store.samhsa.gov/shin/content/SMA07-4301/SMA07-4301.pdf
15.
Substance Abuse and Mental Health Data Archive: Treatment Episode Data Set: Admissions (TEDS-A). Rockville, Md, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality, 2009. Available at www.icpsr.umich.edu/quicktables/quickconfig.do?30462-0001
16.
Vimont C: Report finds majority of publicly funded substance use clinics take Medicaid. Press release. New York, Partnership at Drugfree.org, July 26, 2011. Available at www.drugfree.org/join-together/addiction/report-finds-majority-of-publicly-funded-substance-use-clinics-take-medicaid
17.
Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008. Baltimore, Centers for Medicare and Medicaid Services. Available at www.cms.gov/healthinsreformforconsume/downloads/MHPAEA.pdf
18.
Mark TL, Vandivort-Warren R, Miller K: Mental health spending by private insurance: implications for the Mental Health Parity and Addiction Equity Act. Psychiatric Services 63:313–318, 2012
19.
Health Reform Source: Implementation Timeline. Washington, DC, Kaiser Family Foundation, 2012. Available at healthreform.kff.org/timeline.aspx
20.
Holahan J, Chen V: Changes in Health Insurance Coverage in the Great Recession, 2007–2010. Washington, DC, Kaiser Commission on Medicaid and the Uninsured, 2011. Available at www.kff.org/uninsured/upload/8264.pdf
21.
Enhanced Medicaid Match Rates Expire in June 2011. Washington, DC, Kaiser Commission on Medicaid and the Uninsured, 2011. Available at www.kff.org/medicaid/upload/8205.pdf
22.
Kaiser Family Foundation: Understanding the Medicaid and CHIP Maintenance of Eligibility Requirements. Washington, DC, Kaiser Commission on Medicaid and the Uninsured, 2011. Available at www.kff.org/medicaid/upload/8204.pdf
23.
Honberg R, Diehl S, Kimbal A, et al: State Mental Health Cuts: A National Crisis. Arlington, Va, National Alliance on Mental Illness, 2011. Available at www.nami.org/ContentManagement/ContentDisplay.cfm?ContentFileID=125018
24.
Bowser BA, Winerman L: State Budget Cuts Slash Mental Health Funding. Washington, DC, PBS Newshour, Jan 17, 2011. Available at www.pbs.org/newshour/rundown/2011/01/state-budget-cuts-slash-mental-health-funding.html
25.
Gold J: State’s Mental Health Budgets Fall in Recession. Washington, DC, Kaiser Health News, March 9, 2011. Available at www.kaiserhealthnews.org/Stories/2011/March/09/State-Mental-Health-Budgets-Fall-During-Recession.aspx
26.
Justification of Estimates for Appropriations Committees, Fiscal Year 2012. Rockville, Md, Substance Abuse and Mental Health Services Administration, 2012. Available at www.samhsa.gov/Budget/FY2012/SAMHSA-FY11CJ.pdf
27.
Musumeci MB: A Guide to the Supreme Court’s Affordable Care Act Decision. Washington, DC, Kaiser Family Foundation, 2012. Available at www.kff.org/healthreform/upload/8332.pdf
28.
Garfield RL, Zuvekas SH, Lave JR, et al.: The impact of national health care reform on adults with severe mental disorders. American Journal of Psychiatry 168:486–494, 2011
29.
Brolin M, Quinn A, Sirkin JT, et al: Financing of Behavioral Health Services Within Federally Qualified Health Centers. Truven Health Analytics, July 23, 2012. Available at www.integration.samhsa.gov/Financing_BH_Services_at_FQHCs_Final_7_23-12.pdf
30.
Updated Estimates for the Insurance Coverage Provisions of the Affordable Care Act. Washington, DC, Congressional Budget Office, March 2012. Available at www.cbo.gov/sites/default/files/cbofiles/attachments/03-13-Coverage%20Estimates.pdf

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: Sir Charles, Alias Willie Harris, by Barkley Leonnard Hendricks, 1972. Oil on canvas. William C. Whitney Foundation, 1973.19.1. National Gallery of Art, Washington, D.C.

Psychiatric Services
Pages: 512 - 519
PubMed: 23450375

History

Published in print: June 2013
Published online: 15 October 2014

Authors

Details

Katharine R. Levit, B.A.
Ms. Levit, Dr. Coffey, and Dr. Mark are affiliated with the Behavioral Health and Quality Research Division, Truven Health Analytics (formerly Thomson Reuters Healthcare), where Ms. Stranges and Dr. Kassed were affiliated when this work was done. Dr. Kassed is currently with the American Association for Clinical Chemistry, Washington, D.C. When this work was done, Dr. Buck was with the Center for Mental Health Services and Ms. Vandivort-Warren was with the Center for Substance Abuse Treatment, both at the Substance Abuse and Mental Health Services Administration. Dr. Buck is currently with the Center for Clinical Standards and Quality, Centers for Medicare and Medicaid Services, Baltimore. Ms. Vandivort-Warren is currently with the Office of Special Health Affairs, Health Resources and Services Administration, Rockville, Maryland. Send correspondence to Ms. Levit at Truven Health Analytics, 7700 Old Georgetown Rd., Suite 650, Bethesda, Maryland 20814 (e-mail: [email protected]).
Elizabeth Stranges, M.S.
Ms. Levit, Dr. Coffey, and Dr. Mark are affiliated with the Behavioral Health and Quality Research Division, Truven Health Analytics (formerly Thomson Reuters Healthcare), where Ms. Stranges and Dr. Kassed were affiliated when this work was done. Dr. Kassed is currently with the American Association for Clinical Chemistry, Washington, D.C. When this work was done, Dr. Buck was with the Center for Mental Health Services and Ms. Vandivort-Warren was with the Center for Substance Abuse Treatment, both at the Substance Abuse and Mental Health Services Administration. Dr. Buck is currently with the Center for Clinical Standards and Quality, Centers for Medicare and Medicaid Services, Baltimore. Ms. Vandivort-Warren is currently with the Office of Special Health Affairs, Health Resources and Services Administration, Rockville, Maryland. Send correspondence to Ms. Levit at Truven Health Analytics, 7700 Old Georgetown Rd., Suite 650, Bethesda, Maryland 20814 (e-mail: [email protected]).
Rosanna M. Coffey, Ph.D.
Ms. Levit, Dr. Coffey, and Dr. Mark are affiliated with the Behavioral Health and Quality Research Division, Truven Health Analytics (formerly Thomson Reuters Healthcare), where Ms. Stranges and Dr. Kassed were affiliated when this work was done. Dr. Kassed is currently with the American Association for Clinical Chemistry, Washington, D.C. When this work was done, Dr. Buck was with the Center for Mental Health Services and Ms. Vandivort-Warren was with the Center for Substance Abuse Treatment, both at the Substance Abuse and Mental Health Services Administration. Dr. Buck is currently with the Center for Clinical Standards and Quality, Centers for Medicare and Medicaid Services, Baltimore. Ms. Vandivort-Warren is currently with the Office of Special Health Affairs, Health Resources and Services Administration, Rockville, Maryland. Send correspondence to Ms. Levit at Truven Health Analytics, 7700 Old Georgetown Rd., Suite 650, Bethesda, Maryland 20814 (e-mail: [email protected]).
Cheryl Kassed, Ph.D.
Ms. Levit, Dr. Coffey, and Dr. Mark are affiliated with the Behavioral Health and Quality Research Division, Truven Health Analytics (formerly Thomson Reuters Healthcare), where Ms. Stranges and Dr. Kassed were affiliated when this work was done. Dr. Kassed is currently with the American Association for Clinical Chemistry, Washington, D.C. When this work was done, Dr. Buck was with the Center for Mental Health Services and Ms. Vandivort-Warren was with the Center for Substance Abuse Treatment, both at the Substance Abuse and Mental Health Services Administration. Dr. Buck is currently with the Center for Clinical Standards and Quality, Centers for Medicare and Medicaid Services, Baltimore. Ms. Vandivort-Warren is currently with the Office of Special Health Affairs, Health Resources and Services Administration, Rockville, Maryland. Send correspondence to Ms. Levit at Truven Health Analytics, 7700 Old Georgetown Rd., Suite 650, Bethesda, Maryland 20814 (e-mail: [email protected]).
Tami L. Mark, Ph.D., M.B.A.
Ms. Levit, Dr. Coffey, and Dr. Mark are affiliated with the Behavioral Health and Quality Research Division, Truven Health Analytics (formerly Thomson Reuters Healthcare), where Ms. Stranges and Dr. Kassed were affiliated when this work was done. Dr. Kassed is currently with the American Association for Clinical Chemistry, Washington, D.C. When this work was done, Dr. Buck was with the Center for Mental Health Services and Ms. Vandivort-Warren was with the Center for Substance Abuse Treatment, both at the Substance Abuse and Mental Health Services Administration. Dr. Buck is currently with the Center for Clinical Standards and Quality, Centers for Medicare and Medicaid Services, Baltimore. Ms. Vandivort-Warren is currently with the Office of Special Health Affairs, Health Resources and Services Administration, Rockville, Maryland. Send correspondence to Ms. Levit at Truven Health Analytics, 7700 Old Georgetown Rd., Suite 650, Bethesda, Maryland 20814 (e-mail: [email protected]).
Jeffrey A. Buck, Ph.D.
Ms. Levit, Dr. Coffey, and Dr. Mark are affiliated with the Behavioral Health and Quality Research Division, Truven Health Analytics (formerly Thomson Reuters Healthcare), where Ms. Stranges and Dr. Kassed were affiliated when this work was done. Dr. Kassed is currently with the American Association for Clinical Chemistry, Washington, D.C. When this work was done, Dr. Buck was with the Center for Mental Health Services and Ms. Vandivort-Warren was with the Center for Substance Abuse Treatment, both at the Substance Abuse and Mental Health Services Administration. Dr. Buck is currently with the Center for Clinical Standards and Quality, Centers for Medicare and Medicaid Services, Baltimore. Ms. Vandivort-Warren is currently with the Office of Special Health Affairs, Health Resources and Services Administration, Rockville, Maryland. Send correspondence to Ms. Levit at Truven Health Analytics, 7700 Old Georgetown Rd., Suite 650, Bethesda, Maryland 20814 (e-mail: [email protected]).
Rita Vandivort-Warren, M.S.W.
Ms. Levit, Dr. Coffey, and Dr. Mark are affiliated with the Behavioral Health and Quality Research Division, Truven Health Analytics (formerly Thomson Reuters Healthcare), where Ms. Stranges and Dr. Kassed were affiliated when this work was done. Dr. Kassed is currently with the American Association for Clinical Chemistry, Washington, D.C. When this work was done, Dr. Buck was with the Center for Mental Health Services and Ms. Vandivort-Warren was with the Center for Substance Abuse Treatment, both at the Substance Abuse and Mental Health Services Administration. Dr. Buck is currently with the Center for Clinical Standards and Quality, Centers for Medicare and Medicaid Services, Baltimore. Ms. Vandivort-Warren is currently with the Office of Special Health Affairs, Health Resources and Services Administration, Rockville, Maryland. Send correspondence to Ms. Levit at Truven Health Analytics, 7700 Old Georgetown Rd., Suite 650, Bethesda, Maryland 20814 (e-mail: [email protected]).

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share